HUAWEI DESIGN
833427
Shanghai Kaytune Industrial
301001
Ji Yao Holding Group
300108
Zhengzhou Tiamaes Technology
300807
Jiangsu Canlon Building Materials
300715
CN Stock MarketDetailed Quotes
002399 Shenzhen Hepalink Pharmaceutical Group
- 9.99
- -0.34-3.29%
Noon Break Jan 8 11:30 CST
14.66BMarket Cap-99.90P/E (TTM)
10.38High9.97Low21.62KlotVolume10.30Open10.33Pre Close22.01MTurnover0.17%Turnover RatioLossP/E (Static)1.47BShares12.5452wk High1.21P/B12.46BFloat Cap6.8952wk Low11.36Limit Up1.25BShs Float56.04Historical High9.30Limit Down3.97%Amplitude6.89Historical Low--Dividend TTM10.18Avg Price13.83KlotAsk--Div YieldTTM100Lot Size7.30KlotBid
Shenzhen Hepalink Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 25.21%2.24B | 2.71%2.33B | -14.17%2.23B | -13.43%1.85B | -39.22%1.79B | -35.31%2.27B | -25.32%2.59B | -27.36%2.14B | -21.50%2.95B | 3.69%3.51B |
| Transactional financial assets | 76.47%836.8M | 31.62%333.42M | -42.96%279.64M | -68.42%414.18M | -62.09%474.18M | -81.13%253.31M | -50.41%490.24M | 33.68%1.31B | 214.51%1.25B | 107.83%1.34B |
| Notes receivable and accounts receivable | -3.85%1.2B | 1.23%1.31B | -11.67%1.15B | -21.34%1.26B | -21.69%1.25B | -27.42%1.3B | -21.11%1.31B | 5.10%1.61B | -2.35%1.59B | 4.07%1.79B |
| -Notes receivable | -83.19%1.04M | -84.94%2.43M | -80.93%2.22M | -60.81%3.18M | 2.27%6.21M | 24.62%16.12M | 51.69%11.66M | -18.90%8.12M | -43.52%6.07M | -75.29%12.94M |
| -Accounts receivable | -3.45%1.2B | 2.31%1.31B | -11.04%1.15B | -21.14%1.26B | -21.78%1.24B | -27.80%1.28B | -21.45%1.3B | 5.26%1.6B | -2.07%1.59B | 6.57%1.78B |
| Other receivables (including interest and dividends) | -17.63%91.36M | 199.20%348.85M | -14.05%89.45M | -10.68%120.43M | -36.12%110.91M | -31.73%116.59M | -54.14%104.07M | -44.70%134.82M | -30.93%173.63M | -41.74%170.79M |
| -Other receivable | ---- | 199.20%348.85M | ---- | ---- | ---- | -31.73%116.59M | ---- | -44.70%134.82M | ---- | -41.74%170.79M |
| Contractual assets | 1.95%10.83M | 13.37%11.01M | -46.19%10.97M | -43.96%10.95M | -48.32%10.62M | -42.90%9.72M | 9.04%20.38M | 30.29%19.53M | -2.86%20.56M | -16.14%17.02M |
| Advance payment | -14.91%130.26M | -30.57%115.86M | -35.91%115.47M | -40.22%111.09M | -24.06%153.08M | -25.03%166.88M | -24.00%180.15M | -6.25%185.84M | -13.65%201.58M | -7.92%222.57M |
| Inventories | -28.09%5.61B | -26.26%6.02B | -15.72%6.34B | -2.77%6.65B | 20.02%7.81B | 42.01%8.17B | 48.57%7.52B | 45.38%6.84B | 56.37%6.5B | 59.20%5.75B |
| Other current assets | -7.02%247.43M | -11.43%228.53M | 24.89%222.39M | 19.66%177.92M | 37.56%266.1M | 91.63%258.02M | -0.50%178.07M | -1.66%148.69M | -24.53%193.44M | -47.51%134.65M |
| Total current assets | -12.54%10.37B | -14.62%10.71B | -15.79%10.44B | -14.41%10.6B | -7.95%11.86B | -3.07%12.54B | 4.68%12.4B | 15.04%12.39B | 20.36%12.88B | 27.16%12.94B |
| Non Current assets | ||||||||||
| Other equity investment | 12.98%581.87M | 16.84%606.22M | 2.06%505.82M | -0.71%503.56M | -0.03%515.02M | 5.91%518.85M | 5.80%495.61M | 6.79%507.15M | 3.53%515.18M | -30.27%489.92M |
| Other non-current financial assets | -23.90%802.81M | -19.99%817.11M | -3.34%938.74M | 4.01%1.01B | 13.54%1.05B | 4.56%1.02B | -6.22%971.17M | -2.90%967.58M | 5.30%929.16M | 12.56%976.72M |
| Long-term equity investment | -25.57%496.24M | -29.11%508.84M | 0.36%943.74M | 1.48%1B | -37.27%666.69M | -33.78%717.79M | -15.25%940.38M | -13.70%989.39M | -28.83%1.06B | -29.05%1.08B |
| Long term receivable account | -51.68%517.25K | -47.11%671.78K | -43.02%774.28K | -36.39%950.95K | -26.58%1.07M | -22.06%1.27M | -25.19%1.36M | -23.41%1.5M | -33.10%1.46M | -31.35%1.63M |
| Fixed assets | ---- | -9.56%1.95B | ---- | ---- | ---- | 11.39%2.16B | ---- | -1.94%1.95B | ---- | -5.80%1.94B |
| Constru in process | ---- | 120.63%580.61M | ---- | ---- | ---- | -43.98%263.16M | ---- | -7.24%394.53M | ---- | 19.05%469.79M |
| Intangible assets | -12.38%429.91M | -11.76%448.79M | -9.01%459.78M | -9.24%474.57M | -9.18%490.67M | -4.94%508.59M | -4.88%505.32M | -4.39%522.87M | -4.94%540.24M | -8.04%535.05M |
| Development expenditure | -62.69%19.81M | -62.34%19.39M | -62.67%19.02M | -61.79%18.64M | 9.33%53.09M | 19.17%51.5M | 22.93%50.94M | 22.58%48.79M | 67.72%48.56M | 65.23%43.22M |
| Goodwill | -5.20%2.3B | -4.20%2.34B | 0.29%2.33B | -1.22%2.32B | 1.13%2.42B | 7.66%2.44B | 8.25%2.32B | 9.24%2.35B | 9.47%2.4B | 3.89%2.27B |
| Long deferred expense | -0.52%189.85M | -2.86%190.77M | -1.00%192.08M | -1.78%192.43M | 65.63%190.84M | 69.50%196.39M | 67.40%194.02M | 67.58%195.92M | -2.51%115.23M | -2.79%115.87M |
| Deferred tax assets | 75.31%271.15M | 93.26%259.42M | 112.03%305.28M | 126.54%320.5M | 14.36%154.67M | 6.38%134.24M | 18.01%143.98M | 16.23%141.48M | 91.13%135.25M | 66.87%126.18M |
| Usufruct assets | -20.62%94.3M | -17.35%102.74M | -8.77%115.05M | -13.71%117.09M | -5.55%118.8M | 1.92%124.31M | 0.63%126.12M | 7.57%135.7M | 117.46%125.78M | 103.36%121.96M |
| Other non current assets | -70.06%26.43M | -62.47%41.19M | -13.73%125.83M | -45.48%121.84M | -70.70%88.28M | -56.82%109.76M | -27.64%145.86M | 9.50%223.46M | 50.09%301.26M | 24.19%254.17M |
| Total non current assets | -6.20%7.75B | -4.61%7.87B | 2.55%8.44B | 2.05%8.6B | -3.77%8.26B | -2.10%8.25B | -0.74%8.23B | 1.05%8.43B | 0.29%8.59B | -4.30%8.42B |
| Total assets | -9.94%18.12B | -10.65%18.57B | -8.48%18.87B | -7.75%19.2B | -6.28%20.12B | -2.69%20.79B | 2.45%20.62B | 8.94%20.82B | 11.44%21.47B | 12.57%21.36B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 6.77%1.94B | -29.90%1.63B | -30.16%1.93B | -21.15%1.88B | -40.24%1.82B | -31.87%2.32B | 19.00%2.77B | 26.46%2.39B | 60.05%3.05B | 111.55%3.41B |
| Transactional financial liabilities | --397.85K | ---- | --908.89K | --388.07K | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | 38.70%344M | -10.13%378.17M | -11.91%355.59M | -29.29%302.22M | -42.79%248.01M | -24.08%420.8M | -24.95%403.68M | 10.80%427.43M | 19.90%433.52M | 44.86%554.27M |
| -Notes payable | ---- | ---- | ---- | ---- | --34.67M | --55.29M | --20.62M | ---- | ---- | ---- |
| -Accounts payable | 61.25%344M | 3.46%378.17M | -7.17%355.59M | -29.29%302.22M | -50.79%213.34M | -34.06%365.51M | -28.79%383.05M | 10.80%427.43M | 19.90%433.52M | 44.86%554.27M |
| Contract liabilities | -36.54%256.39M | -16.06%367.64M | -12.42%354.95M | -15.61%366.17M | -12.50%403.99M | -10.56%437.97M | 8.33%405.3M | 13.05%433.88M | -3.61%461.71M | 24.06%489.68M |
| Salaries payable | -7.27%108.57M | -17.99%102.41M | -7.20%154.83M | -10.09%153.71M | -22.05%117.09M | -14.35%124.87M | 7.93%166.84M | 9.41%170.97M | 34.96%150.21M | 31.23%145.8M |
| Taxs payable | 70.36%217.58M | 50.08%232.42M | 88.98%161.59M | 38.07%195.74M | 6.76%127.72M | -3.71%154.86M | -46.43%85.51M | -10.68%141.77M | -35.37%119.63M | -15.06%160.83M |
| Other payable (including interest and dividends) | -9.66%360.3M | -29.21%373.07M | 22.23%441.18M | -11.50%305.57M | 11.69%398.85M | 44.26%526.97M | -1.73%360.94M | -14.37%345.26M | 18.88%357.1M | -33.26%365.29M |
| -Dividend payable | ---- | ---- | ---- | ---- | 285.71%122.69M | 247.65%178.54M | --31.81M | --31.81M | --31.81M | -76.67%51.36M |
| -Other payable | ---- | 7.07%373.07M | ---- | ---- | ---- | 10.99%348.44M | ---- | -22.26%313.46M | ---- | -4.06%313.94M |
| Non current liabilities due within one year | -40.98%1.11B | -8.33%1.4B | 28.34%1.21B | 6.61%1.78B | 12.66%1.88B | -23.28%1.53B | -47.81%943.66M | 18.22%1.67B | 195.12%1.67B | 433.10%1.99B |
| Other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.35%3.36M | 40.36%5.27M |
| Total current liabilities | -13.13%4.34B | -18.74%4.48B | -10.14%4.61B | -10.57%4.99B | -19.94%5B | -22.55%5.51B | -10.43%5.13B | 16.37%5.58B | 59.64%6.24B | 97.01%7.12B |
| Current liabilities | ||||||||||
| Long term loan | -43.66%1.19B | -33.97%1.5B | -14.68%1.71B | 0.55%1.81B | 26.56%2.12B | 106.42%2.27B | 61.83%2.01B | 29.69%1.8B | 14.41%1.67B | -29.01%1.1B |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | -42.45%496.89M | -42.42%496.5M | -68.11%496.11M | -68.11%495.73M |
| Long term account payable | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 |
| Long term salaries pay | -19.44%32.46M | -22.19%33M | -30.12%35.96M | -32.09%35.27M | -41.76%40.29M | -33.85%42.41M | -62.46%51.45M | -62.37%51.94M | -48.70%69.19M | -51.14%64.11M |
| Specific account payable | ---- | 14.65%437.66K | ---- | ---- | ---- | 17.16%381.75K | ---- | 18.77%353.79K | ---- | 20.72%325.83K |
| Estimate liabilities | -2.40%9.64M | -1.37%9.8M | 3.25%9.76M | 1.70%9.74M | 1.13%9.88M | 7.66%9.94M | 1.88%9.45M | 9.24%9.58M | 9.47%9.77M | 3.89%9.23M |
| Deferred tax liabilities | -28.40%239.57M | -26.58%242.46M | -21.56%247.21M | -23.21%252.57M | -12.75%334.58M | 5.87%330.25M | 14.44%315.14M | 19.45%328.92M | 23.51%383.48M | -1.48%311.93M |
| Long term deferred income | -8.55%27.21M | -12.79%28.25M | -16.99%29.11M | -6.52%30.43M | 50.70%29.75M | 85.55%32.4M | 92.58%35.07M | 95.21%32.55M | 14.85%19.74M | -1.40%17.46M |
| Lease liabilities | -31.20%63.72M | -25.54%73.65M | -13.23%88.42M | -18.36%90.42M | -11.14%92.62M | -2.22%98.91M | 1.01%101.9M | 6.49%110.75M | 134.71%104.24M | 121.88%101.16M |
| Total non current liabilities | -40.34%1.57B | -32.25%1.88B | -29.63%2.12B | -21.26%2.23B | -4.76%2.62B | 32.55%2.78B | 14.08%3.02B | 1.34%2.83B | -22.02%2.76B | -42.07%2.1B |
| Total liabilities | -22.50%5.91B | -23.27%6.36B | -17.36%6.74B | -14.17%7.22B | -15.29%7.62B | -10.00%8.29B | -2.69%8.15B | 10.83%8.41B | 20.88%9B | 27.39%9.22B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B | 0.00%1.47B |
| Capital reserve funds | 0.24%5.87B | 0.16%5.87B | 8.48%6.36B | 8.49%6.36B | -1.05%5.85B | -0.97%5.86B | -1.42%5.86B | -1.43%5.86B | -1.01%5.92B | -1.01%5.92B |
| Surplus reserve funds | 0.00%545.38M | 0.00%545.38M | 0.00%545.38M | 0.00%545.38M | 1.60%545.38M | 1.60%545.38M | 1.60%545.38M | 1.60%545.38M | 0.00%536.8M | 0.00%536.8M |
| Retained profit | -3.39%4.17B | -5.66%4.05B | -19.20%3.54B | -21.55%3.39B | 1.52%4.31B | 4.52%4.29B | 12.89%4.38B | 18.34%4.32B | 9.83%4.25B | 8.27%4.11B |
| Other composite income | -59.01%92.86M | -12.57%203.93M | 26.77%153.99M | 26.24%158.46M | 17.70%226.53M | 3,399.28%233.26M | 164.47%121.47M | 168.46%125.52M | 235.52%192.46M | 104.47%6.67M |
| Shareholders equity without minority interests | -2.14%12.14B | -2.12%12.14B | -2.52%12.06B | -3.25%11.91B | 0.36%12.41B | 3.02%12.4B | 6.31%12.38B | 7.90%12.31B | 5.59%12.36B | 3.52%12.03B |
| Minority interests | -20.18%74.14M | -22.37%74.4M | -22.17%74.79M | -22.22%75.23M | -16.20%92.88M | -14.32%95.84M | -14.80%96.09M | -13.61%96.72M | -3.73%110.84M | -5.08%111.86M |
| Total shareholder equity | -2.28%12.21B | -2.27%12.21B | -2.67%12.14B | -3.39%11.99B | 0.22%12.5B | 2.86%12.49B | 6.11%12.47B | 7.69%12.41B | 5.50%12.47B | 3.43%12.15B |
| Total liabilityies and equity | -9.94%18.12B | -10.65%18.57B | -8.48%18.87B | -7.75%19.2B | -6.28%20.12B | -2.69%20.79B | 2.45%20.62B | 8.94%20.82B | 11.44%21.47B | 12.57%21.36B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
